Why Do We Hear More About High Drug Prices Than About Hospital Prices?
In this JAMA Health Forum post, KFF’s Larry Levitt outlines four reasons why high drug prices are in the spotlight...
Key Facts About Medicare Spending Trends and Projections from the 2026 Medicare Trustees Report
On June 9, 2026, the Medicare Trustees issued the annual report on the financial status of the Medicare program for...
How Medicare Advantage Rebates Disadvantage Medicare’s Stand-Alone Drug Plan Market
The Medicare Part D prescription drug benefit was designed to offer Medicare beneficiaries the choice of drug coverage from either...
Medicare Part D Enrollment, Premiums, and Cost Sharing in 2026
The average monthly premium decreased for PDPs in 2026, but the premium for Part D coverage is still substantially higher...
A Look at the GENEROUS Model and Factors That Could Impact Medicaid Drug Costs
While spending on prescription drugs accounts for a relatively small share of overall Medicaid spending, Medicaid drug spending has grown...
What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid
Editorial Note On April 21, 2026, CMS announced that the BALANCE Model will not be implemented in Medicare Part D...
Public Opinion on Prescription Drugs and Their Prices
Many Americans face significant challenges affording their medications, including adults who take more medications or have lower incomes. KFF polling...
Cost Concerns and Coverage Changes: A Follow-Up Survey of ACA Marketplace Enrollees
About the Survey At the end of 2025, despite a government shutdown over the policy, the enhanced premium tax credits...
5 Key Facts About Medicaid Prescription Drugs
Medicaid is the primary program providing comprehensive health and long-term care to low-income people, including access to prescription drugs to treat acute problems...
Recent Trends in GLP-1 Use and Spending in Medicare
Ahead of the Trump administration’s planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the...
